Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
Rising chronic disease prevalence, safer contrast formulations and expanding diagnostic imaging capacity are supporting global market growth. Magnetic Resonance Imaging (MRI) Contrast Agents Market ...
New MRI technology aims to advance neuroimaging and biomarker research CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a ...
Dark, diamond-shaped spots in inner ear magnetic resonance imaging (MRI) scans are not always signs of pathological changes—they can simply result from how a person is positioned in the scanner. A ...
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...
A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging. The ...
Researchers compared the prognostic value of clinically interpreted CT vs MRI for incidentally discovered covert cerebrovascular disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results